TY - JOUR
T1 - Network controllability solutions for computational drug repurposing using genetic algorithms
AU - Popescu, Victor-Bogdan
AU - Kanhaiya, Krishna
AU - Năstac, Dumitru Iulian
AU - Czeizler, Eugen
AU - Petre, Ion
N1 - Funding Information:
This work was partially supported by the Academy of Finland (project 311371/-2017 to E.C.) and by the Romanian National Authority for Scientific Research and Innovation (PED Grant 2391 to I.P.).
Publisher Copyright:
© 2022, The Author(s).
PY - 2022
Y1 - 2022
N2 - Control theory has seen recently impactful applications in network science, especially in connections with applications in network medicine. A key topic of research is that of finding minimal external interventions that offer control over the dynamics of a given network, a problem known as network controllability. We propose in this article a new solution for this problem based on genetic algorithms. We tailor our solution for applications in computational drug repurposing, seeking to maximize its use of FDA-approved drug targets in a given disease-specific protein-protein interaction network. We demonstrate our algorithm on several cancer networks and on several random networks with their edges distributed according to the Erdős–Rényi, the Scale-Free, and the Small World properties. Overall, we show that our new algorithm is more efficient in identifying relevant drug targets in a disease network, advancing the computational solutions needed for new therapeutic and drug repurposing approaches.
AB - Control theory has seen recently impactful applications in network science, especially in connections with applications in network medicine. A key topic of research is that of finding minimal external interventions that offer control over the dynamics of a given network, a problem known as network controllability. We propose in this article a new solution for this problem based on genetic algorithms. We tailor our solution for applications in computational drug repurposing, seeking to maximize its use of FDA-approved drug targets in a given disease-specific protein-protein interaction network. We demonstrate our algorithm on several cancer networks and on several random networks with their edges distributed according to the Erdős–Rényi, the Scale-Free, and the Small World properties. Overall, we show that our new algorithm is more efficient in identifying relevant drug targets in a disease network, advancing the computational solutions needed for new therapeutic and drug repurposing approaches.
UR - http://www.scopus.com/inward/record.url?scp=85123593758&partnerID=8YFLogxK
U2 - 10.1038/s41598-022-05335-3
DO - 10.1038/s41598-022-05335-3
M3 - Article
C2 - 35082323
AN - SCOPUS:85123593758
SN - 2045-2322
VL - 12
JO - Scientific Reports
JF - Scientific Reports
M1 - 1437
ER -